Subconjunctival injection of novel antioxidant nanoparticles inhibits neovascularization after corneal injury
The administration of BP@CS nanoparticles for sustained ROS regulation through local subconjunctival injection represents a new approach to the treatment of pathological corneal neovascularization.
Authors
- Kai Xing (ORCID: https://orcid.org/0000-0002-1525-1780)
- Lin Zhu (ORCID: https://orcid.org/0000-0001-5068-0567)
- Xing Wang (ORCID: https://orcid.org/0000-0002-8537-7186)
- Zefeng Kang
- Jun Zhang
- Jilin Zhou
- Shuyi Hou
Institutions
- Xuzhou Medical College (CN)
- Affiliated Hospital of Xuzhou Medical College (CN)
- Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital (CN)
- Beijing Hospital (CN)
- China Academy of Traditional Chinese Medicine Hospital of Ophthalmology (CN)
- Changzhou Third People's Hospital (CN)
Publication Details
- Journal
- Nanomedicine
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1080/17435889.2026.2647022
- Primary Topic
- Corneal Surgery and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00